https://www.selleckchem.com/pr....oducts/Cyclopamine.h
2% vs. 59.7%; p=0.092). Stay on the intensive care unit (ICU) was significantly longer in the TAE group (mean 8.0 vs. 4.7days; p=0.002). Serious adverse events after re-therapy (12.9% vs. 1.5%; p=0.042) and in-hospital mortality were significantly higher in the TAE group (9.1 vs. 22.6%, OR 2.92 [95% CI 1.04-8.16]; p=0.05). After propensity score matching, the differences found regarding ICU stay (4.9±5.9 and 9.2±11.2; p=0.009) and in-hospital mortality (5% vs. 22.5%; OR 5.52 [95% CI1.11-27.43]; p=0.048) stayed significant. OTSC trea
Like
Comment
Share
